The Synergistic Effects of Menopause and HIV on Cardiovascular Disease Risk in Women
Eligible age
18+ yrs
Accepts
Women
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Menopause is associated with the acceleration of many comorbidities, including cardiovascular disease. Whether HIV and menopause together increase cardiovascular disease risk is a key knowledge gap. The goal of this observational study is to address this knowledge gap by looking at the role of menopause on cardiovascular disease risk factors such as insulin resistance, hypertension, hyperlipidemia, and carotid atherosclerosis using previously collected data. The investigators will look at underlying causes for cardiovascular diseases worsening in menopausal women with HIV by looking at the role of increased inflammation in the body and whether this is altered by weight. The investigators achieve this by enrolling participants who are willing to undergo a whole body MRI.
Sponsor: University of California, San Francisco
You may qualify if…
- ✓ 90 non-pregnant women with HIV (approximately 30 in each menopausal phase) from the San Francisco MWCCS site.
You may not qualify if…
- ✕ Women who are not virally suppressed (HIV RNA \>200 copies/mL)
- ✕ Women who are not on antiretroviral therapy
- ✕ Women who have a history of hysterectomy or oophorectomy
- ✕ Women who are receiving treatment for active cancer or tuberculosis
Where it's recruiting
San Francisco
Source: ClinicalTrials.gov · NCT07284082 · last updated 2026-04-22